MAGARRAY, INC.

Medtech · Defunct

Magneto-nanosensor device for multiplex protein biomarker detection in biological fluids using giant magnetoresistive sensors and magnetic nanoparticle labels

Grants
$941K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$894K
2 awards · Health and Human S
#333 of 4531 in medtech
Patents
27
6 granted · 21 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Topic 240 Early Diagnostics Using Nanotechnologies-based Imaging And Sensing$144,220
Federal contractDepartment of Health and Human Services · R&d-insect & Dis Cont-b Res$749,403
Federal grantDepartment of Health and Human Services · Phase II · Commercialization of Magneto-Nanosensor Immunoassay Platform for Cancer Diagnosis$940,623
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
330VITRUVIAN BIO, LLC$900K—
331COVARIS, INC.$900K—
332Kelyniam Global, Inc.$894K$250K
333MAGARRAY, INC.$894K—
334LIM INNOVATIONS, INC.$892K$11M
335Tissuevision Inc$880K—
336OCT MEDICAL IMAGING, INC.$850K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 6 granted of 27

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.